Diagnosis and Treatment of Community-Acquired Pneumonia in Children

Journal Title: Здоров`я дитини - Year 2016, Vol 1, Issue 69

Abstract

In practice, especially in the outpatient setting, serious problems of pediatrics are early diagnosis and rational therapy of pneumonia in children. The most common pathogens in community-acquired pneumonia are Streptococcus pneumoniae, Haemophilus influenzae and other microorga­nisms, including viruses and fungi. It should be clarified that the etiology of diseases of the lower respiratory tract is very different in various age groups. The most common cause of the community-acquired pneumonia (up to 50 %) is S.pneumoniae, such bacilli as E.сoli, Klebsiella spp., C.trachomatis, Mycoplasma, Ureaplasma are more rare. In children older than 5 years, in the etiological structure of the community-acquired pneumonia, along with S.pneumoniae, the importance of Mycoplasma pneumoniae are increasing. The resistance of pathogens to antibacterial therapy — the growing global problem. Algorithm for the diagnosis of community-acquired pneumonia includes febrile temperature lasting > 3 days, cyanosis, dyspnea in the absence of signs of bronchial obstruction, cough. Tachypnae is one of the best pneumonia predictors in children of all ages. Physical examination reveals the presence of dullness on percussion in the affected area, the bronchial or dimi­nished breath sounds, crackles or wheezing. For the diagnosis of moderate community-acquired pneumonia, it is enough to use clinical symptoms, X-ray of the lungs, common blood test. The initial antibiotic therapy of community-acquired pneumonia is carried out empirically. In the treatment of severe community-acquired pneumonia in children from 2 months to 5 years, the drug of choice is amoxicillin orally. Macrolides are the drugs of choice for children aged 5 to 16 years. In severe pneumonia, drugs of choice are amoxicillin clavulanate, 2nd–4th generation cephalosporins. In general, the duration of antibiotic therapy in the community-acquired pneumonia caused by typical bacteria is 7–10 days, by atypical bacteria — 10–14 days. In the real clinical practice, the errors associated with the choice of drug, route of administration, dosage, regimen of application, length of treatment are frequent during antibacterial therapy.

Authors and Affiliations

I. A. Karymdzhanov, H. Kh. Iskanova, N. A. Israilova

Keywords

Related Articles

Enzyme Therapy in Pediatrics: the Feasibility and Balanced Approaches to Its Implementation

The article considered the role of enzymes in the digestive process, and attention is paid to the problem of exocrine pancreatic insufficiency. Characteristics of enzyme preparations, recommendations for their rational u...

Characteristics of the Course of Chronic Viral Hepatitis in Children

Objective — to study the peculiarities of chronic viral hepatitis B (CHB) in children, depending on the duration of the disease, strain of the virus and viral load. We have examined 61 children aged 3–18 years with CHB....

Social and Psychological Adaptation of Children with Bronchial Asthma to Studying at School

Social and Psychological Adaptation of Children with Bronchial Asthma to Studying at School

Pharmacogenetic Aspects of Airways’ Obstruction Relief Therapy of Bronchial Asthma Attacks in Schoolchildren

On the base of a complex examination of 215 schoolchildren who suffer bronchial asthma, there have been established that clinical manifestations of severity of bronchial obstructive syndrome during disease exacerbation d...

Transient Neonatal Diabetes Associated with Imprinting Disorders in 6Q24 Chromosome. Part 1: Іmprinted Cluster PLAGL1/HYMAI

The article presents modern data on the mechanisms of genetic disorders that lead to the development of neonatal diabetes mellitus associated with the violation of imprin­ting of 6q24 chromosome. This article contains in...

Download PDF file
  • EP ID EP198266
  • DOI -
  • Views 139
  • Downloads 0

How To Cite

I. A. Karymdzhanov, H. Kh. Iskanova, N. A. Israilova (2016). Diagnosis and Treatment of Community-Acquired Pneumonia in Children. Здоров`я дитини, 1(69), 133-138. https://europub.co.uk/articles/-A-198266